Black Diamond Therapeutics Stock Shares Owned By Insiders
| BDTX Stock | USD 2.51 0.03 1.18% |
Black Diamond Therapeutics fundamentals help investors to digest information that contributes to Black Diamond's financial success or failures. It also enables traders to predict the movement of Black Stock. The fundamental analysis module provides a way to measure Black Diamond's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Black Diamond stock.
Black | Shares Owned By Insiders |
Black Diamond Therapeutics Company Shares Owned By Insiders Analysis
Black Diamond's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Black Diamond Shares Owned By Insiders | 2.26 % |
Most of Black Diamond's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Black Diamond Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Black Shares Owned By Insiders Driver Correlations
Understanding the fundamental principles of building solid financial models for Black Diamond is extremely important. It helps to project a fair market value of Black Stock properly, considering its historical fundamentals such as Shares Owned By Insiders. Since Black Diamond's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Black Diamond's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Black Diamond's interrelated accounts and indicators.
Click cells to compare fundamentals
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 2.26% of Black Diamond Therapeutics are shares owned by insiders. This is 85.11% lower than that of the Biotechnology sector and 84.06% lower than that of the Health Care industry. The shares owned by insiders for all United States stocks is 77.6% higher than that of the company.
Black Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Black Diamond's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Black Diamond could also be used in its relative valuation, which is a method of valuing Black Diamond by comparing valuation metrics of similar companies.Black Diamond is currently under evaluation in shares owned by insiders category among its peers.
Black Diamond Current Valuation Drivers
We derive many important indicators used in calculating different scores of Black Diamond from analyzing Black Diamond's financial statements. These drivers represent accounts that assess Black Diamond's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Black Diamond's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.4B | 1.1B | 192.9M | 65.4M | 75.2M | 71.4M | |
| Enterprise Value | 1.5B | 1.0B | 155.5M | 59.2M | 68.1M | 64.7M |
Black Diamond ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Black Diamond's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Black Diamond's managers, analysts, and investors.Environmental | Governance | Social |
Black Fundamentals
| Return On Equity | -0.63 | ||||
| Return On Asset | -0.33 | ||||
| Current Valuation | 54.04 M | ||||
| Shares Outstanding | 56.59 M | ||||
| Shares Owned By Insiders | 2.26 % | ||||
| Shares Owned By Institutions | 98.99 % | ||||
| Number Of Shares Shorted | 6.33 M | ||||
| Price To Book | 1.48 X | ||||
| EBITDA | (86.02 M) | ||||
| Net Income | (82.44 M) | ||||
| Cash And Equivalents | 160.89 M | ||||
| Cash Per Share | 4.43 X | ||||
| Total Debt | 25.3 M | ||||
| Debt To Equity | 0.19 % | ||||
| Current Ratio | 8.55 X | ||||
| Book Value Per Share | 1.72 X | ||||
| Cash Flow From Operations | (66.72 M) | ||||
| Short Ratio | 7.70 X | ||||
| Earnings Per Share | (1.33) X | ||||
| Target Price | 14.5 | ||||
| Number Of Employees | 54 | ||||
| Beta | 2.52 | ||||
| Market Capitalization | 143.73 M | ||||
| Total Asset | 158.57 M | ||||
| Retained Earnings | (417.43 M) | ||||
| Working Capital | 114.39 M | ||||
| Current Asset | 123.51 M | ||||
| Current Liabilities | 4.43 M | ||||
| Net Asset | 158.57 M |
About Black Diamond Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Black Diamond Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Black Diamond using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Black Diamond Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Black Stock Analysis
When running Black Diamond's price analysis, check to measure Black Diamond's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Black Diamond is operating at the current time. Most of Black Diamond's value examination focuses on studying past and present price action to predict the probability of Black Diamond's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Black Diamond's price. Additionally, you may evaluate how the addition of Black Diamond to your portfolios can decrease your overall portfolio volatility.